Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Harding, J. J.; Awada, A.; Kotecki, N.; Aftimos, P.; Decaens, T.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Serdjebi, C.; Brun, S.; Halfon, P.; Raymond, E. |
| Abstract Title: | Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients |
| Meeting Title: | 70th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting (AASLD) |
| Journal Title: | Hepatology |
| Volume: | 70 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Nov 8-12 |
| Meeting Location: | Boston, MA |
| ISSN: | 0270-9139 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2019-10-01 |
| Start Page: | 205A |
| Language: | English |
| ACCESSION: | WOS:000488653500318 |
| PROVIDER: | wos |
| DOI: | 10.1002/hep.30941 |
| Notes: | Meeting Abstract: 319 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
